TULIP Trademark

Trademark Overview

On Monday, March 5, 2018, a trademark application was filed for TULIP with the United States Patent and Trademark Office. The USPTO has given the TULIP trademark a serial number of 79231626. The federal status of this trademark filing is REGISTERED as of Tuesday, January 28, 2020. This trademark is owned by Synthon Biopharmaceuticals B.V. The TULIP trademark is filed in the Education & Entertainment Services and Computer & Software Services & Scientific Services categories with the following description:

Publication of journals, newsletters and scientific papers all featuring the results of clinical trials in the field of anticancer drugs; publication of journals, newsletters and scientific papers all featuring results of clinical trials for pharmaceutical preparations

Performing clinical trials for others relating to pharmaceutical products in the field of anticancer drugs; providing medical and scientific research information on clinical trials in the field of anticancer medicines through an interactive website; providing medical and scientific research information in the field of pharmaceutical products and clinical trials in the field of anticancer drugs; conducting clinical trials for third parties in the field of anticancer drugs; conducting clinical trials for others; performing clinical trials for others in the field of pharmaceutical products; provision of information about the results of clinical trials for pharmaceutical products for scientific and medical research purposes; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing medical and scientific research information about clinical studies via an interactive website; all of the above services directed to pharmaceuti...
tulip

General Information

Serial Number79231626
Word MarkTULIP
Filing DateMonday, March 5, 2018
Status700 - REGISTERED
Status DateTuesday, January 28, 2020
Registration Number5969631
Registration DateTuesday, January 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements

Goods and ServicesPublication of journals, newsletters and scientific papers all featuring the results of clinical trials in the field of anticancer drugs; publication of journals, newsletters and scientific papers all featuring results of clinical trials for pharmaceutical preparations
Goods and ServicesPerforming clinical trials for others relating to pharmaceutical products in the field of anticancer drugs; providing medical and scientific research information on clinical trials in the field of anticancer medicines through an interactive website; providing medical and scientific research information in the field of pharmaceutical products and clinical trials in the field of anticancer drugs; conducting clinical trials for third parties in the field of anticancer drugs; conducting clinical trials for others; performing clinical trials for others in the field of pharmaceutical products; provision of information about the results of clinical trials for pharmaceutical products for scientific and medical research purposes; providing medical and scientific research information in the field of pharmaceutical products and clinical trials; providing medical and scientific research information about clinical studies via an interactive website; all of the above services directed to pharmaceutical companies

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, May 15, 2018
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 15, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBYONDIS B.V.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNL
Party NameSynthon Biopharmaceuticals B.V
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNL
Party NameSynthon Biopharmaceuticals B.V
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNL

Trademark Events

Event DateEvent Description
Monday, November 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 21, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 11, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 29, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, May 9, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 8, 2020FINAL DISPOSITION PROCESSED
Tuesday, April 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Friday, November 8, 2019NOTIFICATION PROCESSED BY IB
Friday, November 1, 2019NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 16, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 16, 2019NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, October 4, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 17, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 10, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 10, 2019FINAL REFUSAL E-MAILED
Wednesday, July 10, 2019FINAL REFUSAL WRITTEN
Thursday, June 20, 2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, June 13, 2019ASSIGNED TO LIE
Thursday, November 15, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 15, 2018LETTER OF SUSPENSION E-MAILED
Thursday, November 15, 2018SUSPENSION LETTER WRITTEN
Thursday, October 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 24, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 24, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 21, 2018REFUSAL PROCESSED BY IB
Thursday, July 5, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 5, 2018REFUSAL PROCESSED BY MPU
Saturday, June 23, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 22, 2018NON-FINAL ACTION WRITTEN
Friday, June 15, 2018ASSIGNED TO EXAMINER
Tuesday, May 22, 2018APPLICATION FILING RECEIPT MAILED
Saturday, May 19, 2018APPLICATION FILING RECEIPT MAILED
Tuesday, May 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 10, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

tulip clinical trials field scientific pharmaceutical anticancer products information research medical